SCHEMBL6824209

SCHEMBL6824209

Clc1nc(NCc2ccccc2Cl)c2ncn(C3CCCC3)c2n1

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 7/20 0.65
▸ ADORA2A P29274 5/20 0.65
▸ PPARD Q03181 1/20 0.65
▸ CDK1 P06493 5/20 0.59
▸ ADORA1 P30542 2/20 0.56
▸ CCNE1 P24864 2/20 0.55
▸ CDK2 P24941 2/20 0.55
▸ CTSL P07711 2/20 0.55
▸ NT5E P21589 2/20 0.53
▸ CCNB2 O95067 1/20 0.51
▸ CCNE2 O96020 1/20 0.51
▸ CDK4 P11802 1/20 0.51
▸ CCNB1 P14635 1/20 0.51
▸ CCND1 P24385 1/20 0.51
▸ FLT3 P36888 1/20 0.51
▸ CCNB3 Q8WWL7 1/20 0.51
▸ CDK5 Q00535 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1355064 0.89 CDK1 (0.69) ADORA3ADORA2APPARDCDK1ADORA1
SCHEMBL6821039 0.89 ADORA3 (0.69) ADORA3ADORA2APPARDCDK1ADORA1
SCHEMBL8179514 0.89 ADORA3 (0.60) ADORA3ADORA2ACDK1ADORA1CCNE1
SCHEMBL1352876 0.89 CDK1 (0.68) ADORA3ADORA2APPARDCDK1ADORA1
SCHEMBL6945844 0.89 ADORA3 (0.69) ADORA3ADORA2APPARDCDK1ADORA1
SCHEMBL6820585 0.88 CDK1 (0.57) ADORA3ADORA2APPARDCDK1ADORA1
SCHEMBL6944125 0.87 ADORA3 (0.68) ADORA3ADORA2ACDK1ADORA1CCNE1
SCHEMBL5193141 0.87 CDK1 (0.78) ADORA3ADORA2ACDK1ADORA1CCNE1
SCHEMBL1352692 0.85 CDK1 (0.63) ADORA3ADORA2APPARDCDK1ADORA1
SCHEMBL25022492 0.83 CDK1 (0.52) ADORA3ADORA2APPARDCDK1ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056745-B1 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES AVENTIS PHARMA INC (US) 2004-06-16 — — EP disclosed
US-6413974-B1 INHIBITORS OF CYCLIN DEPENDENT KINASES, PARTICULARLY CDK-2; PREVENTING APOPTOSIS IN NEURONAL CELLS; ANTINEOPLASTIC AGENTS; NEURONAL INJURY AND DEGENERATION; CEREBROVASCULAR DISEASE AVENTIS PHARMACEUTICALS INC. 2002-07-02 — — US disclosed
EP-1056745-A2 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES Aventis Pharmaceuticals Inc. (US) 2000-12-06 — — EP disclosed
WO-1999043676-A2 6,9-DISUBSTITUTED 2-[TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES AVENTIS PHARMACEUTICALS INC. (US) 1999-09-02 — — WO disclosed
Send feedback